E-LIB Suche - Ergebnisse für: Bardia, A.

1

198P Pembrolizumab plus olaparib vs pembrolizumab plus chem..:

Cussac, A. Llombart ; Rugo, H.S. ; Robson, M.E....
ESMO Open. 9 (2024) - p. 103220 , 2024

Link: https://doi.org/10.1016/..

2

189P The impact of high body mass index (BMI) on the safety..:

Estevez, L. García ; Bardia, A. ; Rugo, H.S....
ESMO Open. 9 (2024) - p. 103211 , 2024

Link: https://doi.org/10.1016/..

3

Neoadjuvant pembrolizumab or placebo + chemotherapy, follow..:

Cardoso, F. ; O'Shaughnessy, J. ; McArthur, H....
European Journal of Cancer. 200 (2024) - p. 113608 , 2024

Link: https://doi.org/10.1016/..

4

LBA2 Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT)..:

Jhaveri, K. ; Bardia, A. ; Im, S-A....
ESMO Open. 9 (2024) - p. 103479 , 2024

Link: https://doi.org/10.1016/..

5

188O EMERALD trial analysis of patient-reported outcomes (P..:

Cortés, J. ; Bidard, F.C. ; Bardia, A....
ESMO Open. 8 (2023) 1 - p. 101377 , 2023

Link: https://doi.org/10.1016/..

6

198P Relationship of diarrhea and neutropenia events with o..:

de Azambuja, E. ; Jacobs, F. ; Lambertini, M....
ESMO Open. 8 (2023) 1 - p. 101387 , 2023

Link: https://doi.org/10.1016/..

7

P018 TROPION-Breast03: Datopotamab deruxtecan (Dato-DXd) ± ..:

Bardia, A. ; Pusztai, L. ; Albain, K....
The Breast. 68 (2023) - p. S23 , 2023

Link: https://doi.org/10.1016/..

8

95MO Circulating tumor DNA (ctDNA) dynamics in patients (pt..:

Gupta, T. ; Garcia, C. ; Biederman, S....
ESMO Open. 8 (2023) 1 - p. 101319 , 2023

Link: https://doi.org/10.1016/..

9

194P Safety outcomes by UGT1A1 status in the phase III TROP..:

Marmé, F. ; Rugo, H.S. ; Tolaney, S.M....
ESMO Open. 8 (2023) 1 - p. 101383 , 2023

Link: https://doi.org/10.1016/..

10

201P Trilaciclib combined with sacituzumab govitecan (SG) i..:

Seneviratne, L. ; Harnden, K.K. ; Mardones, M....
ESMO Open. 8 (2023) 1 - p. 101390 , 2023

Link: https://doi.org/10.1016/..

11

Pooled ctDNA analysis of MONALEESA phase III advanced breas..:

André, F. ; Su, F. ; Solovieff, N....
Annals of Oncology. 34 (2023) 11 - p. 1003-1014 , 2023

Link: https://doi.org/10.1016/..

12

A Phase I Study of Adjuvant Niraparib Administered Concurre..:

Keenan, J.C. ; Dunn, S.A. ; Collins, M.E....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. S44 , 2022

Link: https://doi.org/10.1016/..

13

Sacituzumab govitecan, a Trop-2-directed antibody-drug conj..:

Bardia, A. ; Messersmith, W.A. ; Kio, E.A....
Annals of Oncology. 32 (2021) 6 - p. 746-756 , 2021

Link: https://doi.org/10.1016/..

14

Biomarker analyses in the phase III ASCENT study of sacituz..:

Bardia, A. ; Tolaney, S.M. ; Punie, K....
Annals of Oncology. 32 (2021) 9 - p. 1148-1156 , 2021

Link: https://doi.org/10.1016/..

15

Sacituzumab govitecan in previously treated hormone recepto..:

Kalinsky, K. ; Diamond, J.R. ; Vahdat, L.T....
Annals of Oncology. 31 (2020) 12 - p. 1709-1718 , 2020

Link: https://doi.org/10.1016/..